59 research outputs found
ΠΠ½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ΅ Π»Π°Π·Π΅ΡΠ½ΠΎΠ΅ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΊΠ°ΠΊ ΡΡΠΈΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°ΡΠΏΠ΅ΠΊΡ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π°
The research purpose is to study the effect of intravenous laser blood illumination (ILBI) on the hematological parameters and the character of personality characteristics in patients of reproductive age with external forms of endometriosis in the form of endometrioid ovarian cysts. Materials and methods. The study included two groups of patients: the main group I (n=43) consisted of patients who received hormone therapy + ILBI; the comparison group II (n=37) consisted of patients who received hormone therapy. In all study groups a questionnaire was conducted to determine the level of compliance, considered as acceptance of the doctor's position by the patient, conviction in his professionalism, agreement to follow his instructions. The questionnaire was developed in accordance with the requirements for psycho-diagnostic questionnaires. The assessment of pain was carried out by a subjective 5-point verbal scale. The analysis of hematologic parameters of blood was conducted this way: hemoglobin was analyzed on the MEDONIC M-series analyzer module M20 produced in Sweden; the coagulation system (fibrinogen by the Rutberg method, activated partial thromboplastin time (APTT), prothrombin index (PTI) by Quick) was evaluated on a biochemical analyzer Dirui CS-T240 produced in China. Results. The overall decrease in the pain syndrome was observed in group I: the frequency of complaints with the highest pain score (5 points) decreased to 21.6% (n=9); the indicator "4 points" decreased to 18.6% (n=8). The indicator "3 points" increased to 16.3% (n=7); "2 points" - up to 11.6% (n=5), "1 point" - up to 6.97% (n=3) and "0" points - up to 25.6% (n=11). Patients of group I developed moderate hemodilution and stabilization of the blood hematologic potential. Median parameters of hemoglobin, hematocrit and erythrocyte sedimentation rate (ESR) showed a significant decrease: at U=4.6 p<0.0001 and U=3.05 p<0.002; U=6.2, p<0.0001 (respectively). The analysis of the content of fibrinogen during intra-group comparison formed its significant decrease (U=4.7, with p<0.0001). The activated partial thromboplastin time (APTT) in patients of group I was reliably shortened (U=7.3, with p<0.0001), the level of prothrombin was also significantly lowered compared to baseline data (U=4.8, p<0.0001 ). At average values of the compliance level for the whole selection (M=7.14, c=2.83), the highest parameters in group I (M=9.4, a=1.31) are most pronounced, which is significantly higher than in the comparison group (M=4.51, c=1.56, with t=15.03 p<0.001). Conclusion. A marked improvement in the rheological properties of blood in patients with external forms of endometriosis and reduction in pain syndrome is observed against the background of combined hormonal therapy and ILBI. The use of ILBI in the therapy of external forms of endometriosis, restoring the objective status of the patient, contributes to the increase of "doctor-patient" communication.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ - ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²Π»ΠΈΡΠ½ΠΈΡ Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π»Π°Π·Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΈ (ΠΠΠΠ) Π½Π° Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ Π»ΠΈΡΠ½ΠΎΡΡΠ½ΡΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ° Π½Π°ΡΡΠΆΠ½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π° Π² Π²ΠΈΠ΄Π΅ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠΈΠ΄Π½ΡΡ
ΠΊΠΈΡΡ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ². ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΎΡΠ»ΠΈ Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²: Π² ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ I (n=43) ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΠ΅ Π³ΠΎΡΠΌΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ + Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ΅ Π»Π°Π·Π΅ΡΠ½ΠΎΠ΅ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΠ΅; Π² Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ II (n=37) ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΠ΅ Π³ΠΎΡΠΌΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ. ΠΠΎ Π²ΡΠ΅Ρ
ΠΎΠ±ΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π°Π½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π° Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΠΊΠΎΠΌΠΏΠ»Π°ΠΉΠ½ΡΠ° (compliance), ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΊΠ°ΠΊ ΠΏΡΠΈΠ½ΡΡΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΌ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ Π²ΡΠ°ΡΠ°, ΡΠ±Π΅ΠΆΠ΄Π΅Π½Π½ΠΎΡΡΡ Π² Π΅Π³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΠΈΠ·ΠΌΠ΅, ΡΠΎΠ³Π»Π°ΡΠΈΠ΅ ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ Π΅Π³ΠΎ ΡΠΊΠ°Π·Π°Π½ΠΈΡΠΌ. ΠΠ½ΠΊΠ΅ΡΠ° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΡΡΠ΅Π±ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ ΠΊ ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π²ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ°ΠΌ. ΠΡΠ΅Π½ΠΊΠ° Π±ΠΎΠ»ΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΏΠΎ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ 5-Π±Π°Π»Π»ΡΠ½ΠΎΠΉ Π²Π΅ΡΠ±Π°Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π»Π΅. ΠΠ½Π°Π»ΠΈΠ· Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΡΠΎΠ²ΠΈ: Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, ΠΏΡΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½ Π½Π° Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ MEDONIC ΡΠ΅ΡΠΈΠΈ Π ΠΌΠΎΠ΄ΡΠ»Ρ Π20, ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π° Π¨Π²Π΅ΡΠΈΡ; ΡΠ²Π΅ΡΡΡΠ²Π°ΡΡΠ°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° ΠΎΡΠ΅Π½Π΅Π½Π° Π½Π° Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ Dirui CS-T240 ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΠΈΡΠ°ΠΉ: ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½ ΠΏΠΎ Π ΡΡΠ±Π΅ΡΠ³Ρ, Π°ΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠ΅ ΡΡΠΎΠΌΠ±ΠΎΠΏΠ»Π°ΡΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ, ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΈΠ½ΠΎΠ²ΡΠΉ ΠΈΠ½Π΄Π΅ΠΊΡ ΠΏΠΎ ΠΠ²ΠΈΠΊΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΈΡ
ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. Π‘ΡΠΌΠΌΠ°ΡΠ½ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π°ΠΊΡΠΈΠ²Π½ΠΎ ΠΏΡΠΎΡΠ²ΠΈΠ»ΠΎΡΡ Π² Π³ΡΡΠΏΠΏΠ΅ I: ΡΠ°ΡΡΠΎΡΠ° ΠΆΠ°Π»ΠΎΠ± Ρ Π½Π°ΠΈΠ²ΡΡΡΠΈΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΌ Π±ΠΎΠ»ΠΈ (5 Π±Π°Π»Π»ΠΎΠ²) ΡΠ½ΠΈΠ·ΠΈΠ»Π°ΡΡ Π΄ΠΎ 21,6% (n=9); ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Β«4 Π±Π°Π»Π»Π°Β» ΡΠΌΠ΅Π½ΡΡΠΈΠ»ΡΡ Π΄ΠΎ 18,6% (n=8). ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Β«3 Π±Π°Π»Π»Π°Β» Π²ΠΎΠ·ΡΠΎΡ Π΄ΠΎ 16,3% (n=7); Β«2 Π±Π°Π»Π»Π°Β» - Π΄ΠΎ 11,6% (n=5), Β«1 Π±Π°Π»Π»Β» - Π΄ΠΎ 6,97% (n=3) ΠΈ Β«0Β» Π±Π°Π»Π»ΠΎΠ² - Π΄ΠΎ 25,6% (n=11). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ I, ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π»Π°ΡΡ ΡΠΌΠ΅ΡΠ΅Π½Π½Π°Ρ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ»ΡΡΠΈΡ ΠΈ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΡ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»Π° ΠΊΡΠΎΠ²ΠΈ. ΠΠ΅Π΄ΠΈΠ°Π½Π½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, Π³Π΅ΠΌΠ°ΡΠΎΠΊΡΠΈΡΠ° ΠΈ Π‘ΠΠ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠΌ ΠΈΡ
ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠΈ: ΠΏΡΠΈ U=4,6 p<0,0001 ΠΈ U=3,05 Ρ<0,002; U=6,2, Ρ<0,0001 (ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). ΠΠ½Π°Π»ΠΈΠ· ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½Π° ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π²Π½ΡΡΡΠΈΠ³ΡΡΠΏΠΏΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π» Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ Π΅Π³ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ (U=4,7, ΠΏΡΠΈ p<0,0001). ΠΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠ΅ ΡΡΠΎΠΌΠ±ΠΎΠΏΠ»Π°ΡΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ I Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠΊΠΎΡΠΎΡΠ΅Π½ΠΎ (U=7,3, ΠΏΡΠΈ p<0,0001), ΡΠ°ΠΊΠΆΠ΅ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ ΡΡΠΎΠ²Π΅Π½Ρ ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΈΠ½Π° Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ (U=4,8, Ρ<0,0001). ΠΡΠΈ ΡΡΠ΅Π΄Π½ΠΈΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΡΡ
ΡΡΠΎΠ²Π½Ρ ΠΊΠΎΠΌΠΏΠ»Π°ΠΉΠ½ΡΠ° Π² ΡΠ΅Π»ΠΎΠΌ ΠΏΠΎ Π²ΡΠ±ΠΎΡΠΊΠ΅ (Π=7,14; ΠΎ=2,83), Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Ρ Π²ΡΡΠΎΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π² Π³ΡΡΠΏΠΏΠ΅ I (Π=9,4; ΠΎ=1,31), ΡΡΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ (Π=4,51; ΓΆ=1,56; ΠΏΡΠΈ t=15,03 Ρ<0,001). ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ° ΡΠΎΠ½Π΅ ΡΠΎΡΠ΅ΡΠ°Π½Π½ΠΎΠΉ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ Π»Π°Π·Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΡ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠ΅ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ²ΠΎΠΉΡΡΠ² ΠΊΡΠΎΠ²ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π½Π°ΡΡΠΆΠ½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π° ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π° Π² ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π°ΡΡΠΆΠ½ΡΡ
ΡΠΎΡΠΌ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π°, Π²ΠΎΡΡΡΠ°Π½Π°Π²Π»ΠΈΠ²Π°Ρ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΡΠ°ΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΊΠΎΠΌΠΌΡΠ½ΠΈΠΊΠ°ΡΠΈΠΈ Β«ΠΡΠ°Ρ-Π±ΠΎΠ»ΡΠ½ΠΎΠΉΒ»
Interferon- and immunotherapy in the treatment of immunocompromised children with recurrent acute respiratory infections associated with different recurrent and latent herpesviral infections
ΠΠ½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ΅ Π»Π°Π·Π΅ΡΠ½ΠΎΠ΅ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΊΠ°ΠΊ ΡΡΠΈΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°ΡΠΏΠ΅ΠΊΡ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π°
The research purpose is to study the effect of intravenous laser blood illumination (ILBI) on the hematological parameters and the character of personality characteristics in patients of reproductive age with external forms of endometriosis in the form of endometrioid ovarian cysts. Materials and methods. The study included two groups of patients: the main group I (n=43) consisted of patients who received hormone therapy + ILBI; the comparison group II (n=37) consisted of patients who received hormone therapy. In all study groups a questionnaire was conducted to determine the level of compliance, considered as acceptance of the doctor's position by the patient, conviction in his professionalism, agreement to follow his instructions. The questionnaire was developed in accordance with the requirements for psycho-diagnostic questionnaires. The assessment of pain was carried out by a subjective 5-point verbal scale. The analysis of hematologic parameters of blood was conducted this way: hemoglobin was analyzed on the MEDONIC M-series analyzer module M20 produced in Sweden; the coagulation system (fibrinogen by the Rutberg method, activated partial thromboplastin time (APTT), prothrombin index (PTI) by Quick) was evaluated on a biochemical analyzer Dirui CS-T240 produced in China. Results. The overall decrease in the pain syndrome was observed in group I: the frequency of complaints with the highest pain score (5 points) decreased to 21.6% (n=9); the indicator "4 points" decreased to 18.6% (n=8). The indicator "3 points" increased to 16.3% (n=7); "2 points" - up to 11.6% (n=5), "1 point" - up to 6.97% (n=3) and "0" points - up to 25.6% (n=11). Patients of group I developed moderate hemodilution and stabilization of the blood hematologic potential. Median parameters of hemoglobin, hematocrit and erythrocyte sedimentation rate (ESR) showed a significant decrease: at U=4.6 p<0.0001 and U=3.05 p<0.002; U=6.2, p<0.0001 (respectively). The analysis of the content of fibrinogen during intra-group comparison formed its significant decrease (U=4.7, with p<0.0001). The activated partial thromboplastin time (APTT) in patients of group I was reliably shortened (U=7.3, with p<0.0001), the level of prothrombin was also significantly lowered compared to baseline data (U=4.8, p<0.0001 ). At average values of the compliance level for the whole selection (M=7.14, c=2.83), the highest parameters in group I (M=9.4, a=1.31) are most pronounced, which is significantly higher than in the comparison group (M=4.51, c=1.56, with t=15.03 p<0.001). Conclusion. A marked improvement in the rheological properties of blood in patients with external forms of endometriosis and reduction in pain syndrome is observed against the background of combined hormonal therapy and ILBI. The use of ILBI in the therapy of external forms of endometriosis, restoring the objective status of the patient, contributes to the increase of "doctor-patient" communication.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ - ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²Π»ΠΈΡΠ½ΠΈΡ Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π»Π°Π·Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΈ (ΠΠΠΠ) Π½Π° Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ Π»ΠΈΡΠ½ΠΎΡΡΠ½ΡΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ° Π½Π°ΡΡΠΆΠ½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π° Π² Π²ΠΈΠ΄Π΅ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠΈΠ΄Π½ΡΡ
ΠΊΠΈΡΡ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ². ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΎΡΠ»ΠΈ Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²: Π² ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ I (n=43) ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΠ΅ Π³ΠΎΡΠΌΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ + Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ΅ Π»Π°Π·Π΅ΡΠ½ΠΎΠ΅ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΠ΅; Π² Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ II (n=37) ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΠ΅ Π³ΠΎΡΠΌΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ. ΠΠΎ Π²ΡΠ΅Ρ
ΠΎΠ±ΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π°Π½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π° Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΠΊΠΎΠΌΠΏΠ»Π°ΠΉΠ½ΡΠ° (compliance), ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΊΠ°ΠΊ ΠΏΡΠΈΠ½ΡΡΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΌ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ Π²ΡΠ°ΡΠ°, ΡΠ±Π΅ΠΆΠ΄Π΅Π½Π½ΠΎΡΡΡ Π² Π΅Π³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΠΈΠ·ΠΌΠ΅, ΡΠΎΠ³Π»Π°ΡΠΈΠ΅ ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ Π΅Π³ΠΎ ΡΠΊΠ°Π·Π°Π½ΠΈΡΠΌ. ΠΠ½ΠΊΠ΅ΡΠ° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΡΡΠ΅Π±ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ ΠΊ ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π²ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ°ΠΌ. ΠΡΠ΅Π½ΠΊΠ° Π±ΠΎΠ»ΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΏΠΎ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ 5-Π±Π°Π»Π»ΡΠ½ΠΎΠΉ Π²Π΅ΡΠ±Π°Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π»Π΅. ΠΠ½Π°Π»ΠΈΠ· Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΡΠΎΠ²ΠΈ: Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, ΠΏΡΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½ Π½Π° Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ MEDONIC ΡΠ΅ΡΠΈΠΈ Π ΠΌΠΎΠ΄ΡΠ»Ρ Π20, ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π° Π¨Π²Π΅ΡΠΈΡ; ΡΠ²Π΅ΡΡΡΠ²Π°ΡΡΠ°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° ΠΎΡΠ΅Π½Π΅Π½Π° Π½Π° Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ Dirui CS-T240 ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΠΈΡΠ°ΠΉ: ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½ ΠΏΠΎ Π ΡΡΠ±Π΅ΡΠ³Ρ, Π°ΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠ΅ ΡΡΠΎΠΌΠ±ΠΎΠΏΠ»Π°ΡΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ, ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΈΠ½ΠΎΠ²ΡΠΉ ΠΈΠ½Π΄Π΅ΠΊΡ ΠΏΠΎ ΠΠ²ΠΈΠΊΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΈΡ
ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. Π‘ΡΠΌΠΌΠ°ΡΠ½ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π°ΠΊΡΠΈΠ²Π½ΠΎ ΠΏΡΠΎΡΠ²ΠΈΠ»ΠΎΡΡ Π² Π³ΡΡΠΏΠΏΠ΅ I: ΡΠ°ΡΡΠΎΡΠ° ΠΆΠ°Π»ΠΎΠ± Ρ Π½Π°ΠΈΠ²ΡΡΡΠΈΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΌ Π±ΠΎΠ»ΠΈ (5 Π±Π°Π»Π»ΠΎΠ²) ΡΠ½ΠΈΠ·ΠΈΠ»Π°ΡΡ Π΄ΠΎ 21,6% (n=9); ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Β«4 Π±Π°Π»Π»Π°Β» ΡΠΌΠ΅Π½ΡΡΠΈΠ»ΡΡ Π΄ΠΎ 18,6% (n=8). ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Β«3 Π±Π°Π»Π»Π°Β» Π²ΠΎΠ·ΡΠΎΡ Π΄ΠΎ 16,3% (n=7); Β«2 Π±Π°Π»Π»Π°Β» - Π΄ΠΎ 11,6% (n=5), Β«1 Π±Π°Π»Π»Β» - Π΄ΠΎ 6,97% (n=3) ΠΈ Β«0Β» Π±Π°Π»Π»ΠΎΠ² - Π΄ΠΎ 25,6% (n=11). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ I, ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π»Π°ΡΡ ΡΠΌΠ΅ΡΠ΅Π½Π½Π°Ρ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ»ΡΡΠΈΡ ΠΈ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΡ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»Π° ΠΊΡΠΎΠ²ΠΈ. ΠΠ΅Π΄ΠΈΠ°Π½Π½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, Π³Π΅ΠΌΠ°ΡΠΎΠΊΡΠΈΡΠ° ΠΈ Π‘ΠΠ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠΌ ΠΈΡ
ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠΈ: ΠΏΡΠΈ U=4,6 p<0,0001 ΠΈ U=3,05 Ρ<0,002; U=6,2, Ρ<0,0001 (ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). ΠΠ½Π°Π»ΠΈΠ· ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½Π° ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π²Π½ΡΡΡΠΈΠ³ΡΡΠΏΠΏΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π» Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ Π΅Π³ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ (U=4,7, ΠΏΡΠΈ p<0,0001). ΠΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠ΅ ΡΡΠΎΠΌΠ±ΠΎΠΏΠ»Π°ΡΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ I Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠΊΠΎΡΠΎΡΠ΅Π½ΠΎ (U=7,3, ΠΏΡΠΈ p<0,0001), ΡΠ°ΠΊΠΆΠ΅ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ ΡΡΠΎΠ²Π΅Π½Ρ ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΈΠ½Π° Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ (U=4,8, Ρ<0,0001). ΠΡΠΈ ΡΡΠ΅Π΄Π½ΠΈΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΡΡ
ΡΡΠΎΠ²Π½Ρ ΠΊΠΎΠΌΠΏΠ»Π°ΠΉΠ½ΡΠ° Π² ΡΠ΅Π»ΠΎΠΌ ΠΏΠΎ Π²ΡΠ±ΠΎΡΠΊΠ΅ (Π=7,14; ΠΎ=2,83), Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Ρ Π²ΡΡΠΎΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π² Π³ΡΡΠΏΠΏΠ΅ I (Π=9,4; ΠΎ=1,31), ΡΡΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ (Π=4,51; ΓΆ=1,56; ΠΏΡΠΈ t=15,03 Ρ<0,001). ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ° ΡΠΎΠ½Π΅ ΡΠΎΡΠ΅ΡΠ°Π½Π½ΠΎΠΉ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ Π»Π°Π·Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠΈΠ²Π°Π½ΠΈΡ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠ΅ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ²ΠΎΠΉΡΡΠ² ΠΊΡΠΎΠ²ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π½Π°ΡΡΠΆΠ½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π° ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π° Π² ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π°ΡΡΠΆΠ½ΡΡ
ΡΠΎΡΠΌ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΎΠ·Π°, Π²ΠΎΡΡΡΠ°Π½Π°Π²Π»ΠΈΠ²Π°Ρ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΡΠ°ΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΊΠΎΠΌΠΌΡΠ½ΠΈΠΊΠ°ΡΠΈΠΈ Β«ΠΡΠ°Ρ-Π±ΠΎΠ»ΡΠ½ΠΎΠΉΒ»
Interferon- and immunotherapy in the treatment of immunocompromised children with recurrent acute respiratory infections associated with different recurrent and latent herpesviral infections
ΠΠΠΠ- Π ΠΠΠΠΠΠΠΠ ΠΠΠΠΠΠΠ― ΠΠΠΠ£ΠΠΠ’ΠΠ ΠΠΠΠ― ΠΠΠΠ£ΠΠΠΠΠΠΠ ΠΠΠΠ’ΠΠ ΠΠΠΠΠΠ«Π₯ ΠΠΠ’ΠΠ Π‘ ΠΠΠΠΠ ΠΠ’ΠΠ«ΠΠ ΠΠ-ΠΠΠ€ΠΠΠ¦ΠΠ―ΠΠ
Remodeling of phenotype and functional activity of neutrophilic granulocytes in immunocompromised children with recurrent viral and bacterial infections as results of the interferon- and the immunotherapy
PHENOTYPIC CHARACTERISTICS OF SUBPOPULATIONS OF NEUTROPHILIC GRANULOCYTES FULL-TERM NEWBORNS WITH CONGENITAL PNEUMONIA AND NEONATAL SEPSIS
Experimental Remodeling in Vitro of Transformed CD16+CD32+CD11b+Phenotype Subset of Neutrophilic Granulocytes in Patients with Atypical Chronic Bacterial Infection
The positive transformation of the phenotype, the functional activity of neutrophilic granulocytes in children with recurrent respiratory infections as treatment' results of interferon and immunomodulation therapy
The present study showed the presence of the negative transformation of phenotype and defects of phagocytic function of neutrophil granulocytes (NG) in immunocompromised children with recurrent acute respiratory viral infections (ARVI), associated with different herpes viral infections (HVI) and chronic diseases of upper respiratory tract (CDURT). Prolonged and adequate interferon' therapy in combination with immunomodulatory therapy had demonstrated a high clinical efficacy, accompanied the reorganization of the base functions of NG: the positive transformation of the membrane expression of the functionally significant receptors CD64, CD32, CD16, CD11b and the modulation of the defective phagocytic activity to normal activity
Phenotypic characteristics of the monocyte subpopulations CD64+CD16-CD32+CD11b+, CD64+CD16+ CD32+CD11b+, CD64-CD16+ CD32+CD11b+ in deeply premature newborns with congenital pneumonia
Early detection of infectious-inflammatory and purulent-septic processes in deeply premature newborns is very difficult and extremely urgent in modern neonatology. The aim of our study was to identify the phenotypic characteristics of subpopulations CD64+CD16-CD32+CD11b+, CD64+CD16+CD32+CD11b+, CD64-CD16+CD32+CD11b+ monocytes (Mon) with definition of their diagnostic value in deeply premature newborns with the congenital pneumonia varying severity and the respiratory distress syndrome. There was investigated a momentary expression of molecules DD64, CD32, DD16, CD11b on the surface membrane of Mon by the flow cytometry. The testing of the level of their density was done, using detection of the mean intensity of the fluorescence (MFI). For the first time demonstrated the existence of different subpopulations CD64+CD16-CD32+CD11b+, CD64+CD16+CD32+CD11b+, CD64-CD16+CD32+CD11b+ Mon in healthy newborn infants and transformation of the phenotype of these subpopulations in deeply premature newborns with the congenital pneumonia varying severity and the respiratory distress syndrome. These features of quantitative and qualitative transformation of 3 subpopulations of Mon were correlated with the severity of congenital pneumonia in deeply premature newborns. The study of the level of the subpopulation CD64-CD16+CD32+CD11b+ Mon can be used as an early diagnostic marker of gravity of inflammatory process in severe congenital pneumonia in deeply premature newborns
- β¦